Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal
Granados, Carlos Eduardo
Cardona, Andrés Felipe
MetadataShow full item record
Background: Although randomized clinical trials (RCTs) are considered the gold standard of evidence, their reporting is often suboptimal. Trial registries have the potential to contribute important methodologic information for critical appraisal of study results. Methods and Findings: The objective
of the study was to evaluate the reporting of key methodologic study characteristics in trial registries. We identified a random sample (n = 265) of actively recruiting RCTs using the World Health Organization International Clinical Trials Registry Platform (ICTRP) search portal in 2008. We assessed the reporting of relevant domains from the Cochrane Collaboration’s ‘Risk of bias’ tool and other key methodological aspects. Our primary outcomes were the proportion of registry records with adequate reporting of random sequence generation, allocation concealment, blinding, and trial outcomes. Two reviewers independently assessed each record. Weighted overall proportions in the ICTRP search portal for adequate reporting of sequence generation, allocation concealment, blinding (including and excluding open label RCT) and primary outcomes were 5.7% (95% CI 3.0–8.4%), 1.4% (0–2.8%), 41% (35–47%), 8.4% (4.1–13%), and 66% (60–72%), respectively. The proportion of adequately reported RCTs was higher for registries that used specific methodological fields for describing methods of randomization and allocation concealment compared to registries that did not. Concerning other key methodological aspects, weighted overall proportions of RCTs with adequately reported items were as follows: eligibility criteria (81%), secondary outcomes (46%), harm (5%) follow-up duration (62%), description of the interventions (53%) and sample size calculation (1%). Conclusions: Trial registries currently contain limited methodologic information about registered RCTs. In order to permit adequate critical appraisal of trial results reported in journals and registries, trial registries should consider requesting details on key RCT methods to complement journal publications. Full protocols remain the most comprehensive source of methodologic information and should be made publicly available.
Is part ofPLoS ONE, 2010, vol. 5, núm. 8, e12484
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial Misericòrdia, Carles; Martínez Alonso, Montserrat; Pons Rodríguez, Anna; Pérez Lacasta, María José; Perestelo Pérez, Lilisbeth; Sala, Maria; Vidal, Carmen; Garcia, Montse; Toledo Chávarri, Ana; Codern, Núria; Feijoo Cid, Maria; Romero, Anabel; Pla, Roger; Soler González, Jorge; Castells, Xavier; Rué i Monné, Montserrat (BioMed Central, 2017)The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary ...
Poorer Quality of Life and Treatment Satisfaction is Associated with Diabetic Retinopathy in Patients with Type 1 Diabetes without Other Advanced Late Complications Granado Casas, Minerva; Castelblanco Echavarría, Esmeralda; Ramírez-Morros, Anna; Martín, Mariona; Alcubierre Calvo, Núria; Martínez Alonso, Montserrat; Valldeperas, Xavier; Traveset Maeso, Alicia; Rubinat, Esther; Lucas-Martin, Ana; Hernández, Marta; Alonso, Núria; Mauricio Puente, Dídac (MDPI, 2019-03-18)Diabetic retinopathy (DR) may potentially cause vision loss and affect the patient's quality of life (QoL) and treatment satisfaction (TS). Using specific tools, we aimed to assess the impact of DR and clinical factors on ...
Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial Pérez Lacasta, María José; Martínez Alonso, Montserrat; Garcia, Montse; Sala, Maria; Perestelo Pérez, Lilisbeth; Vidal, Carmen; Codern-Bové, Núria; Feijoo Cid, Maria; Toledo Chávarri, Ana; Cardona, Àngels; Pons, Anna; Carles Lavila, Misericordia; Rué i Monné, Montserrat (Public Library of Science, 2019-03-26)BACKGROUND: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits ...